ZA989424B - Purification of molecules. - Google Patents

Purification of molecules.

Info

Publication number
ZA989424B
ZA989424B ZA9809424A ZA989424A ZA989424B ZA 989424 B ZA989424 B ZA 989424B ZA 9809424 A ZA9809424 A ZA 9809424A ZA 989424 A ZA989424 A ZA 989424A ZA 989424 B ZA989424 B ZA 989424B
Authority
ZA
South Africa
Prior art keywords
contaminants
molecules
molecule
purification
column
Prior art date
Application number
ZA9809424A
Other languages
English (en)
Inventor
Robert L Fahrner
David Reifsnyder
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of ZA989424B publication Critical patent/ZA989424B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/65Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
ZA9809424A 1997-10-24 1998-10-15 Purification of molecules. ZA989424B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95776097A 1997-10-24 1997-10-24

Publications (1)

Publication Number Publication Date
ZA989424B true ZA989424B (en) 2000-04-17

Family

ID=25500093

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9809424A ZA989424B (en) 1997-10-24 1998-10-15 Purification of molecules.

Country Status (13)

Country Link
EP (1) EP1025126B1 (ja)
JP (1) JP4239131B2 (ja)
AT (1) ATE237636T1 (ja)
AU (1) AU740665B2 (ja)
CA (1) CA2306447C (ja)
DE (1) DE69813599T2 (ja)
DK (1) DK1025126T3 (ja)
ES (1) ES2195409T3 (ja)
HK (1) HK1031387A1 (ja)
IL (1) IL135087A (ja)
PT (1) PT1025126E (ja)
WO (1) WO1999021889A1 (ja)
ZA (1) ZA989424B (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE382057T1 (de) 2001-06-28 2008-01-15 Novo Nordisk As Stabile formulierung von modifiziertem glp-1
JP4936884B2 (ja) 2003-06-03 2012-05-23 ノボ・ノルデイスク・エー/エス 安定化された薬学的ペプチド組成物
PL1633391T3 (pl) 2003-06-03 2012-03-30 Novo Nordisk As Stabilizowane farmaceutycznie kompozycje peptydowe
HUE038395T2 (hu) 2003-11-20 2018-10-29 Novo Nordisk As Propilén-glikol tartalmú peptidkészítmények, amelyek elõállításra és injekciós eszközökben történõ alkalmazásra optimálisak
JP4965446B2 (ja) * 2004-08-31 2012-07-04 ノヴォ ノルディスク アー/エス ペプチド、ポリペプチド及びタンパク質の安定化のためのトリス(ヒドロキシメチル)アミノメタンの使用
AU2005303777B2 (en) 2004-11-12 2010-12-16 Novo Nordisk A/S Stable formulations of insulinotropic peptides
EP1966232A1 (en) 2005-12-23 2008-09-10 Novo Nordisk A/S Purification of proteins using preparative reverse phase chromatography (rpc)
AU2011343813B2 (en) 2010-12-15 2015-05-21 Takeda Pharmaceutical Company Limited Eluate collection using conductivity gradient
TWI762706B (zh) 2017-08-24 2022-05-01 丹麥商諾佛 儂迪克股份有限公司 Glp-1組成物及其用途
BR112022013795A2 (pt) 2020-02-18 2022-09-13 Novo Nordisk As Composição farmacêutica líquida, e, kit

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4743680A (en) * 1985-02-01 1988-05-10 New York University Method for purifying antihemophilic factor
US5446024A (en) * 1993-12-17 1995-08-29 Genentech, Inc. Purification of insulin-like growth factor

Also Published As

Publication number Publication date
WO1999021889A1 (en) 1999-05-06
ATE237636T1 (de) 2003-05-15
PT1025126E (pt) 2003-09-30
HK1031387A1 (en) 2001-06-15
CA2306447C (en) 2009-04-07
IL135087A (en) 2005-05-17
EP1025126A1 (en) 2000-08-09
DE69813599T2 (de) 2004-04-08
EP1025126B1 (en) 2003-04-16
DK1025126T3 (da) 2003-08-04
DE69813599D1 (de) 2003-05-22
ES2195409T3 (es) 2003-12-01
JP2001521044A (ja) 2001-11-06
AU1072599A (en) 1999-05-17
CA2306447A1 (en) 1999-05-06
AU740665B2 (en) 2001-11-08
JP4239131B2 (ja) 2009-03-18

Similar Documents

Publication Publication Date Title
ZA951372B (en) Antibody purification
DK0906122T3 (da) Aktiverede linkers og fremgangsmåde til at fremstille og oprense disse
ZA989424B (en) Purification of molecules.
BR9916101A (pt) Purificação de compostos de ciclopeptìdeos equinocandinos
DE69417617D1 (de) Kolonne für Flüssigkeitschromatographie
MX9707909A (es) Purificacion de anticuerpos.
AU3951589A (en) Peptide derivatives containing proline and leucine for use in affinity chromatography and a process for the preparation thereof
ZA944950B (en) Protein purification
PT703788E (pt) Fenilanina-amonio-liasa estabilizada
AU4733293A (en) Purification of oxygen by cryogenic adsorption
AU6834294A (en) Metal chelates as spacer compounds in biologically active peptides
EP0644769A4 (en) BIOLOGICALLY ACTIVE PEPTIDES WITH N-TERMINAL SUBSTITUTIONS.
AU7466996A (en) An isolated and purified dna molecule and protein for the degradation of triazine compounds
HK1039130A1 (en) Method for chromatographically purifying insulins
ZA934780B (en) A process for recovering a recombinant protein in biologically active from a solution containing inactive protein
AU7062198A (en) Purification of peptides and oligonucleotides by sample displacement chromatography process and apparatus
DK0833919T3 (da) Type F botulintoksin og anvendelse deraf
DK118789D0 (da) Fremgangsmaade til affinitetschromatografisk rensning af a-underenheden af faktor xiii
Basak et al. Affinity purification of proteinases by a combination of immobilized peptidyl aldehyde and semicarbazone
KR940005284A (ko) 면역친화성 크로마토그래피에 의한 플라스미노겐 활성화제 억제제 2의 정제방법
ATE175214T1 (de) Methode zur trennung von glykosylierten und unglykosylierten proteinen
IT9047695A0 (it) Analizzatore automatico in cromatografia liquida ad elevata risoluzione (hplc) per il trattamento e la purificazione dei campioni e per la determinazione di sostanze in essi contenute.
HU9200507D0 (en) Novel method for the indentification of biologically active peptides from peptide mixtures in attacment-testing experiments
TW239078B (en) Pharmaceutical and veterinary composition for inhibiting metastasis
KR970009339B1 (en) Tpa from scolopendra subepinpes multilans and its purification method